|
US4661499A
(en)
|
1985-06-18 |
1987-04-28 |
Merck Frosst Canada, Inc. |
2-[(substituted)-phenoxymethyl]quinolines
|
|
GB9122590D0
(en)
*
|
1991-10-24 |
1991-12-04 |
Lilly Industries Ltd |
Pharmaceutical compounds
|
|
WO1994006802A1
(fr)
|
1992-09-18 |
1994-03-31 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Compose de thienodiazepine et son utilisation medicinale
|
|
ES2062943B1
(es)
|
1993-03-23 |
1995-11-16 |
Uriach & Cia Sa J |
Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.
|
|
US5486612A
(en)
*
|
1993-12-14 |
1996-01-23 |
Eli Lilly And Company |
N-benzyl dihydroindole LTD4 antagonists
|
|
FR2734265B1
(fr)
|
1995-05-17 |
1997-06-13 |
Adir |
Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant
|
|
US5783586A
(en)
|
1996-10-01 |
1998-07-21 |
Abbott Laboratories |
Heteroarylmethoxyphenylthioalkyl carboxylates as inhibitors of leukotriene biosynthesis
|
|
EP0968179B1
(en)
*
|
1997-02-25 |
2002-09-25 |
Syngenta Participations AG |
N-sulphonyl and n-sulphinyl amino acid amides as microbiocides
|
|
ATE233104T1
(de)
*
|
1997-09-18 |
2003-03-15 |
Janssen Pharmaceutica Nv |
Kondensierte imidazolderivate zur erhöhung der oralen bioverfügbarkeit von pharmazeutika
|
|
DE10007203A1
(de)
|
2000-02-17 |
2001-08-23 |
Asta Medica Ag |
Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
|
|
PL359619A1
(en)
|
2000-06-23 |
2004-08-23 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
JP2004513935A
(ja)
|
2000-11-17 |
2004-05-13 |
ノボ ノルディスク アクティーゼルスカブ |
グルカゴンアンタゴニスト／逆アゴニスト
|
|
US20030203946A1
(en)
|
2000-11-17 |
2003-10-30 |
Carsten Behrens |
Glucagon antagonists/inverse agonists
|
|
US20050070506A1
(en)
*
|
2002-01-18 |
2005-03-31 |
Doherty George A. |
Selective s1p1/edg1 receptor agonists
|
|
WO2004063147A1
(en)
|
2003-01-10 |
2004-07-29 |
Novo Nordisk A/S |
Salts and solvates of glucagon antagonists
|
|
US7329682B2
(en)
|
2003-04-03 |
2008-02-12 |
Ewha University-Industry Collaboration Foundation |
Method for inhibiting 5-lipoxygenase using a benzoxazole derivative
|
|
CN1856490A
(zh)
*
|
2003-07-28 |
2006-11-01 |
詹森药业有限公司 |
苯并咪唑、苯并噻唑和苯并噁唑衍生物及其作为lta4h调节剂的应用
|
|
UA86283C2
(uk)
|
2005-01-07 |
2009-04-10 |
Пфайзер Продактс Инк. |
Гетероароматичні сполуки хіноліну і їх застосування як інгібіторів pde10
|
|
US20060223792A1
(en)
*
|
2005-03-31 |
2006-10-05 |
Butler Christopher R |
Phenyl and pyridyl LTA4H modulators
|
|
PE20070335A1
(es)
|
2005-08-30 |
2007-04-21 |
Novartis Ag |
Benzimidazoles sustituidos y metodos para su preparacion
|
|
US7939528B2
(en)
*
|
2005-10-13 |
2011-05-10 |
Glaxosmithkline Llc |
Heterocycle compounds
|
|
DE102006021878A1
(de)
|
2006-05-11 |
2007-11-15 |
Sanofi-Aventis |
Phenylamino-benzoxazol substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
WO2008057280A1
(en)
|
2006-10-27 |
2008-05-15 |
Amgen Inc. |
Multi-cyclic compounds and methods of use
|
|
TW200906396A
(en)
*
|
2007-02-14 |
2009-02-16 |
Janssen Pharmaceutica Nv |
LTA4H modulators and uses thereof
|
|
AU2008256922B2
(en)
|
2007-05-23 |
2011-07-28 |
Novartis Ag |
Raf inhibitors for the treatment of thyroid cancer
|
|
AR069126A1
(es)
*
|
2007-10-31 |
2009-12-30 |
Janssen Pharmaceutica Nv |
Diaminas en puente o fusionadas sustituidas con arilo como moduladores de leucotrieno a4 hidrolasa
|
|
US9446995B2
(en)
|
2012-05-21 |
2016-09-20 |
Illinois Institute Of Technology |
Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
|
|
SI2336125T1
(sl)
*
|
2008-04-11 |
2013-04-30 |
Janssen Pharmaceutica N.V. |
Tiazolopiridin-2-iloksi-fenil in tiazolopirazin-2-iloksi-fenil amini kot modulatorji levkotrien a4 hidrolaze
|
|
WO2009132202A2
(en)
|
2008-04-24 |
2009-10-29 |
Incyte Corporation |
Macrocyclic compounds and their use as kinase inhibitors
|
|
MX2010013683A
(es)
|
2008-06-13 |
2011-04-26 |
Novartis Ag |
Bencimidazoles sustituidos para neurofibromatosis.
|
|
TW201010977A
(en)
|
2008-08-12 |
2010-03-16 |
Takeda Pharmaceutical |
Amide compound
|
|
WO2010059163A1
(en)
|
2008-11-21 |
2010-05-27 |
Hassan Hamza |
Adjustable vacuum relief safety valve system for swimming pools and spas
|
|
PT2391366E
(pt)
|
2009-01-29 |
2013-02-05 |
Novartis Ag |
Benzimidazoles substituídos para o tratamento de astrocitomas
|
|
WO2014077401A1
(ja)
|
2012-11-19 |
2014-05-22 |
武田薬品工業株式会社 |
含窒素複素環化合物
|
|
WO2014129796A1
(en)
|
2013-02-20 |
2014-08-28 |
Lg Life Sciences Ltd. |
Sphingosine-1-phosphate receptor agonists, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
|
|
CN104045552B
(zh)
|
2013-03-13 |
2019-06-11 |
江苏先声药业有限公司 |
作为神经保护剂的药用化合物
|
|
US20160101106A1
(en)
|
2013-05-07 |
2016-04-14 |
Inhibikase Therapeutics, Inc. |
Methods for treating hcv infection
|
|
SG11201509351UA
(en)
|
2013-06-10 |
2015-12-30 |
Bayer Pharma AG |
Novel compounds for the treatment of cancer
|
|
EP3102569A1
(en)
|
2014-02-06 |
2016-12-14 |
AbbVie Inc. |
6-heteroaryloxy- and 6-aryloxy-quinoline-2-carboxamides and uses thereof
|
|
SG11201609050UA
(en)
*
|
2014-05-30 |
2016-12-29 |
Pfizer |
Carbonitrile derivatives as selective androgen receptor modulators
|
|
EP3328860B2
(en)
|
2015-07-28 |
2022-11-02 |
UDC Ireland Limited |
Process for the preparation of benzimidazo[1,2-a]benzimidazoles
|
|
BR112018003711A2
(pt)
*
|
2015-08-26 |
2018-09-25 |
Texas A & M Univ Sys |
método para sensibilização de um parasita a um fármaco e método para prevenir infecção sintomática de um paciente por um parasita ou tratar infecção de um paciente por um parasita com um fármaco
|
|
AR111495A1
(es)
|
2017-05-01 |
2019-07-17 |
Theravance Biopharma R&D Ip Llc |
Compuestos de imidazo-piperidina fusionada como inhibidores de jak
|
|
CN107383014B
(zh)
|
2017-06-21 |
2019-04-30 |
南方医科大学 |
一种1H-吡唑并[3,4-d]嘧啶类化合物及其制备方法和应用
|
|
EP3908278A4
(en)
*
|
2019-01-11 |
2022-09-28 |
Naegis Pharmaceuticals Inc. |
INHIBITORS OF LEUKOTRIEN SYNTHESIS
|